Ontology highlight
ABSTRACT:
SUBMITTER: Nazha A
PROVIDER: S-EPMC7609542 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
Nazha Aziz A Hu Zhen-Huan ZH Wang Tao T Lindsley R Coleman RC Abdel-Azim Hisham H Aljurf Mahmoud M Bacher Ulrike U Bashey Asad A Cahn Jean-Yves JY Cerny Jan J Copelan Edward E DeFilipp Zachariah Z Diaz Miguel Angel MA Farhadfar Nosha N Gadalla Shahinaz M SM Gale Robert Peter RP George Biju B Gergis Usama U Grunwald Michael R MR Hamilton Betty B Hashmi Shahrukh S Hildebrandt Gerhard C GC Inamoto Yoshihiro Y Kalaycio Matt M Kamble Rammurti T RT Kharfan-Dabaja Mohamed A MA Lazarus Hillard M HM Liesveld Jane L JL Litzow Mark R MR Majhail Navneet S NS Murthy Hemant S HS Nathan Sunita S Nishihori Taiga T Pawarode Attaphol A Rizzieri David D Sabloff Mitchell M Savani Bipin N BN Schachter Levanto L Schouten Harry C HC Seo Sachiko S Shah Nirav N NN Solh Melhem M Valcárcel David D Vij Ravi R Warlick Erica E Wirk Baldeep B Wood William A WA Yared Jean A JA Alyea Edwin E Popat Uday U Sobecks Ronald M RM Scott Bart L BL Nakamura Ryotaro R Saber Wael W
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20200808 11
Allogeneic hematopoietic stem cell transplantation (HCT) remains the only potentially curative option for myelodysplastic syndromes (MDS). Mortality after HCT is high, with deaths related to relapse or transplant-related complications. Thus, identifying patients who may or may not benefit from HCT is clinically important. We identified 1514 patients with MDS enrolled in the Center for International Blood and Marrow Transplant Research Registry and had their peripheral blood samples sequenced for ...[more]